Vaccine News and Research

Latest Vaccine News and Research

Protecting HIV patients from Hep B

Since the transmission of HIV and Hepatitis B virus (HBV) are so similar, individuals infected with one of these viruses are at a significantly increased risk for contracting the other.

19 Jul 2007

GSK's Cervarix receives positive opinion in Europe

GlaxoSmithKline has announced that its cervical cancer candidate vaccine received a positive opinion from the European Committee for Human Medicinal Products (CHMP) for the prevention of precancerous lesions (high grade cervical intraepithelial neoplasia - CIN grades 2 and 3) and cervical cancer causally related to human papillomavirus types 16 and 18.

19 Jul 2007

Orchestra Therapeutics discontinues HIV vaccine program

Orchestra Therapeutics, Inc. has announced the discontinuation of its HIV Vaccine Development Program.

18 Jul 2007

Test of universal influenza vaccine

A universal influenza vaccine that has been pioneered by researchers from VIB and Ghent University is being tested for the first time on humans by the British-American biotech company Acambis.

18 Jul 2007

HIV-infected children may require repeat measles vaccination

The researchers found that only half of the HIV-infected children who survived without antiretroviral therapy maintained protective antibody levels 27 months after receiving measles vaccine.

18 Jul 2007

Consortium to fight malaria caused by Plasmodium vivax

The CRESIB has presented the research programme on malaria by Plasmodium vivax, a parasite causing over 70 million yearly cases of malaria in the world.

18 Jul 2007

Curry chemical bisdemethoxycurcumin may clear amyloid beta plaques

FINDINGS: Researchers isolated bisdemethoxycurcumin, the active ingredient of curcuminoids – a natural substance found in turmeric root – that may help boost the immune system in clearing amyloid beta, a peptide that forms the plaques found in Alzheimer's disease.

17 Jul 2007

Inverse relationship between mortality rates and performance in the hospital quality alliance measures

A new study from the Harvard School of Public Health (HSPH) shows that patients who go to hospitals ranked higher according to specific quality measures have a lower chance of dying than patients treated at lower-ranked hospitals.

17 Jul 2007

Myeloid-derived suppressor cells suppress anti-tumor response to cancer

Scientists at Johns Hopkins and elsewhere say they have mapped out an escape route that cancers use to evade the body's immune system, allowing the disease to spread unchecked.

17 Jul 2007

Children at birthday party paid by 'MMR row' doctor for their blood

The General Medical Council (GMC) in Britain has heard that Dr. Andrew Wakefield, who is facing allegations of serious professional misconduct with regard to research on the triple measles-mumps-rubella MMR vaccine, paid children £5 to take their blood samples at his son's birthday party.

16 Jul 2007

Experts in Britain wholeheartedly back MMR jab

A disciplinary hearing due to begin this week in the UK may well settle the debate over any link between the measles, mumps and rubella vaccine (MMR) and autism.

16 Jul 2007

Paint helps surgeons see where a tumor begins and ends

A tumor paint developed by researchers at Seattle Children's Hospital Research Institute and Fred Hutchinson Cancer Research Center will help surgeons see where a tumor begins and ends more precisely by illuminating the cancerous cells.

16 Jul 2007

Do vaccines promote a false sense of security?

A new study examines whether a vaccine that offers only partial protection can backfire by increasing risky behavior, as a false sense of security could make recipients less careful than they otherwise would be.

16 Jul 2007

Bavarian Nordic granted new European patent on modified vaccinia virus Ankara

The European Patent Organisation (EPO) has granted a patent to Bavarian Nordic which further strengthens its intellectual property position on MVA in Europe.

12 Jul 2007

Novavax licenses virus-like particle from Wyeth

Novavax, Inc. has announced that is has signed a non-exclusive, worldwide license agreement with Wyeth, to obtain rights to a patent application covering virus-like particle (VLP) technology for use in human vaccines in certain fields of use.

10 Jul 2007

Women's HIV/AIDS conference delegates develop action plan to foster women's, girls' leadership in fight against disease

Delegates on Saturday at the close of the first International Women's Summit on Women's Leadership and HIV and AIDS in Nairobi, Kenya, released a 10-point action plan that aims to foster leadership roles of women and girls in the fight against HIV/AIDS, the Nation/AllAfrica.com reports.

10 Jul 2007